These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28596421)

  • 21. Incidence, mortality, and cardiovascular diseases in pituitary adenoma in Korea: a nationwide population-based study.
    Oh JS; Kim HJ; Hann HJ; Kang TU; Kim DS; Kang MJ; Lee JY; Shim JJ; Lee MR; Ahn HS
    Pituitary; 2021 Feb; 24(1):38-47. PubMed ID: 32949324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mortality in patients treated for Cushing's disease is increased, compared with patients treated for nonfunctioning pituitary macroadenoma.
    Dekkers OM; Biermasz NR; Pereira AM; Roelfsema F; van Aken MO; Voormolen JH; Romijn JA
    J Clin Endocrinol Metab; 2007 Mar; 92(3):976-81. PubMed ID: 17200171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colorectal cancer death after adenoma removal in Scandinavia.
    Emilsson L; Løberg M; Bretthauer M; Holme Ø; Fall K; Jodal HC; Adami HO; Kalager M
    Scand J Gastroenterol; 2017 Dec; 52(12):1377-1384. PubMed ID: 28906163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucocorticoid replacement therapy is independently associated with reduced bone mineral density in women with hypopituitarism.
    Ragnarsson O; Nyström HF; Johannsson G
    Clin Endocrinol (Oxf); 2012 Feb; 76(2):246-52. PubMed ID: 21767286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebrovascular mortality in patients with pituitary adenoma.
    Brada M; Ashley S; Ford D; Traish D; Burchell L; Rajan B
    Clin Endocrinol (Oxf); 2002 Dec; 57(6):713-7. PubMed ID: 12460319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Excess mortality and morbidity in patients with craniopharyngioma, especially in patients with childhood onset: a population-based study in Sweden.
    Olsson DS; Andersson E; Bryngelsson IL; Nilsson AG; Johannsson G
    J Clin Endocrinol Metab; 2015 Feb; 100(2):467-74. PubMed ID: 25375987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of glucocorticoid replacement on bone mineral density in patients with hypopituitarism before and after 2 years of growth hormone replacement therapy.
    Ragnar Agnarsson H; Johannsson G; Ragnarsson O
    J Clin Endocrinol Metab; 2014 Apr; 99(4):1479-85. PubMed ID: 24423362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New Neoplasm During GH Replacement in Adults With Pituitary Deficiency Following Malignancy: A KIMS Analysis.
    Krzyzanowska-Mittermayer K; Mattsson AF; Maiter D; Feldt-Rasmussen U; Camacho-Hübner C; Luger A; Abs R
    J Clin Endocrinol Metab; 2018 Feb; 103(2):523-531. PubMed ID: 29228199
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship of each anterior pituitary hormone deficiency to the size of non-functioning pituitary adenoma in the hospitalized patients.
    Mukai K; Kitamura T; Tamada D; Murata M; Otsuki M; Shimomura I
    Endocr J; 2016 Nov; 63(11):965-976. PubMed ID: 27534814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment Factors That Influence Mortality in Acromegaly.
    McCabe J; Ayuk J; Sherlock M
    Neuroendocrinology; 2016; 103(1):66-74. PubMed ID: 25661647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of long-term growth hormone replacement in adults with growth hormone deficiency following cure of acromegaly: a KIMS analysis.
    Tritos NA; Johannsson G; Korbonits M; Miller KK; Feldt-Rasmussen U; Yuen KC; King D; Mattsson AF; Jonsson PJ; Koltowska-Haggstrom M; Klibanski A; Biller BM
    J Clin Endocrinol Metab; 2014 Jun; 99(6):2018-29. PubMed ID: 24694339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group.
    Tomlinson JW; Holden N; Hills RK; Wheatley K; Clayton RN; Bates AS; Sheppard MC; Stewart PM
    Lancet; 2001 Feb; 357(9254):425-31. PubMed ID: 11273062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postoperative mortality in parathyroid surgery in Sweden during five decades: improved outcome despite older patients.
    Norenstedt S; Ekbom A; Brandt L; Zedenius J; Nilsson IL
    Eur J Endocrinol; 2009 Feb; 160(2):295-9. PubMed ID: 19042978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term recurrence and mortality after surgery and adjuvant radiotherapy for nonfunctional pituitary adenomas.
    Chang EF; Zada G; Kim S; Lamborn KR; Quinones-Hinojosa A; Tyrrell JB; Wilson CB; Kunwar S
    J Neurosurg; 2008 Apr; 108(4):736-45. PubMed ID: 18377253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing progression of non-functioning pituitary adenomas in hypopituitarism patients with and without long-term GH replacement therapy.
    Olsson DS; Buchfelder M; Schlaffer S; Bengtsson BA; Jakobsson KE; Johannsson G; Nilsson AG
    Eur J Endocrinol; 2009 Nov; 161(5):663-9. PubMed ID: 19734242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An evaluation of the effects of somatostatin analogue therapy in non-functioning pituitary adenomas in comparison to acromegaly.
    Zawada NB; Kunert-Radek J; Pawlikowski M; Pisarek H; Radek M
    Endokrynol Pol; 2016; 67(3):292-8. PubMed ID: 27345147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction in daily hydrocortisone dose improves bone health in primary adrenal insufficiency.
    Schulz J; Frey KR; Cooper MS; Zopf K; Ventz M; Diederich S; Quinkler M
    Eur J Endocrinol; 2016 Apr; 174(4):531-8. PubMed ID: 26811406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fractures in pituitary adenoma patients from the Dutch National Registry of Growth Hormone Treatment in Adults.
    van Varsseveld NC; van Bunderen CC; Franken AA; Koppeschaar HP; van der Lely AJ; Drent ML
    Pituitary; 2016 Aug; 19(4):381-90. PubMed ID: 27048484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GH deficiency after traumatic brain injury: improvement in quality of life with GH therapy: analysis of the KIMS database.
    Gardner CJ; Mattsson AF; Daousi C; Korbonits M; Koltowska-Haggstrom M; Cuthbertson DJ
    Eur J Endocrinol; 2015 Apr; 172(4):371-81. PubMed ID: 25583905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucocorticoid dose thresholds associated with all-cause and cardiovascular mortality in rheumatoid arthritis.
    del Rincón I; Battafarano DF; Restrepo JF; Erikson JM; Escalante A
    Arthritis Rheumatol; 2014 Feb; 66(2):264-72. PubMed ID: 24504798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.